Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
A Retrospective Claims Data Analysis on the Burden of COVID-19-Related Hospitalization in Adults at High Risk for Severe Disease Progression in Germany.
Infect Dis Ther
December 2024
Pfizer Pharma GmbH, Berlin, Germany.
Introduction: Individuals at increased risk of severe coronavirus disease 2019 (COVID-19) progression have a higher probability of being hospitalized. Nirmatrelvir/ritonavir (NMV/r) is an antiviral drug aiming to prevent severe disease courses. Our study aimed to assess the resource utilization and costs of adults hospitalized for COVID-19 at high risk for severe disease progression.
View Article and Find Full Text PDFEarly impacts of the Pennsylvania Rural Health Model on potentially avoidable utilization.
Health Aff Sch
February 2024
Department of Health Policy and Management, University of Pittsburgh School of Public Health, Pittsburgh, PA 15261, United States.
The Pennsylvania Rural Health Model (PARHM) is a novel alternative payment model for rural hospitals that aims to test whether hospital-based global budgets, coupled with delivery transformation plans, improve the quality of health care and health outcomes in rural communities. Eighteen hospitals joined PARHM in 3 cohorts between 2019 and 2021. This study assessed PARHM's impact on changes in potentially avoidable utilization (PAU)-a measure of admission rates policymakers explicitly targeted for improvement in PARHM.
View Article and Find Full Text PDFAMCP Partnership Forum: The evolving role of digital therapeutics.
J Manag Care Spec Pharm
July 2022
Digital health tools, specifically digital therapeutics (DTx), which are primarily used to prevent, manage, and treat medical conditions, pose both challenges and opportunities to the health care system. To address needs related to coverage evaluation and access to DTx, AMCP held a virtual multistakeholder forum from August 31 to September 1, 2021. The group of 41 experts convened included representatives from payer, pharmacy benefit manager, integrated delivery system, patient advocacy, and DTx innovator organizations, along with individual health economists, academicians, and other key stakeholders.
View Article and Find Full Text PDFUser Experience and Sustainability of 3D Printing in Dentistry.
Int J Environ Res Public Health
February 2022
Department of Prosthodontics, Semmelweis University, Szentkiralyi utca 47., 1088 Budapest, Hungary.
Background: 3D printing is a rapidly developing technology in the healthcare industry and in dentistry. Its application clearly shows that this area of digital dentistry has potential for everyday usage across all fields, including prosthodontics, orthodontics, maxillofacial surgery, and oral implantology. However, despite gaining ground, there is a lack of information about how specialists (dentists and dental technicians) use additive technology.
View Article and Find Full Text PDFEconomic burden of varicella in Europe in the absence of universal varicella vaccination.
BMC Public Health
December 2021
University of Basel Children's Hospital (UKBB), Spitalstrasse 33, 4056, Basel, Switzerland.
Background: Though the disease burden of varicella in Europe has been reported previously, the economic burden is still unknown. This study estimated the economic burden of varicella in Europe in the absence of Universal Varicella Vaccination (UVV) in 2018 Euros from both payer (direct costs) and societal (direct and indirect costs) perspectives.
Methods: We estimated the country specific and overall annual costs of varicella in absence of UVV in 31 European countries (27 EU countries, plus Iceland, Norway, Switzerland and the United Kingdom).
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!